The earnings call reflects a strong performance by MDxHealth, with consistent revenue growth driven by tissue-based tests and improved gross margins. However, challenges remain with increased net loss and the impact of a significant earn-out payment. Overall, the company's strategic positioning and future outlook appear positive, but financial losses present ongoing challenges.

Company Guidance -

Q1 2025

During the MDxHealth First Quarter 2025 Earnings Conference Call, the company reaffirmed its financial guidance, projecting revenue between $108 million to $110 million for the fiscal year of 2025, aligning with their objective of 20% revenue growth. The call highlighted a 22% increase in Q1 revenue to $24.3 million and a 41% growth in tissue-based test volumes. Total billable volumes reached approximately 24,000 tests, up 24% from the previous year. The company emphasized its strong market position in precision diagnostics for prostate cancer, driven by successful integration and adoption of their Confirm mdx and GPS tests, which accounted for 85% of Q1 revenue. MDxHealth also reported a gross margin increase to 63.8% and expected to achieve positive adjusted EBITDA in Q2 2025, showcasing operational discipline and sustained growth across their urology diagnostic offerings.

Consistent Revenue Growth

Achieved 16th consecutive quarter of 20% or greater revenue growth, with Q1 2025 revenue growth at 22%.

Strong Tissue-Based Test Performance

Tissue-based test volume grew 41% for the quarter, indicating significant market penetration and acceptance.

Improved Gross Profit and Margin

Gross profit increased 29% to $15.5 million, with gross margins rising to 63.8% from 60.8% in Q1 2024.

Positive Adjusted EBITDA Trend

Adjusted EBITDA improved by 71% to negative $1.3 million, with expectations to achieve positive adjusted EBITDA in Q2 2025.

Strategic Positioning in Prostate Cancer Diagnostics

MDxHealth positioned as a leader with proprietary tests like Confirm and GPS, capturing a significant portion of a $500 million market opportunity.

MDxHealth (MDXH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MDXH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 14, 2025	2025 (Q2)	-0.12 / -	-0.42	―	―	―
May 14, 2025	2025 (Q1)	-0.13 / -0.19	-0.31	38.71% (+0.12)	―
Feb 26, 2025	2024 (Q4)	-0.19 / -0.14	-0.39	64.10% (+0.25)	―
Nov 06, 2024	2024 (Q3)	-0.27 / -0.40	-0.4	0.00% (0.00)
Aug 21, 2024	2024 (Q2)	-0.28 / -0.42	-0.4	-5.00% (-0.02)	―
May 01, 2024	2024 (Q1)	-0.30 / -0.31	-0.5	38.00% (+0.19)	―
Mar 06, 2024	2023 (Q4)	-0.21 / -0.39	-1.06	63.21% (+0.67)	―
Nov 08, 2023	2023 (Q3)	-0.30 / -0.40	-0.5	20.00% (+0.10)	―
Aug 23, 2023	2023 (Q2)	-0.33 / -0.40	-0.665	39.85% (+0.27)	―	―
May 15, 2023	2023 (Q1)	-0.41 / -0.50	-0.5	0.00% (0.00)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MDXH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 14, 2025	$1.78	$1.90	+6.74%
Feb 26, 2025	$1.83	$1.86	+1.64%
Nov 06, 2024	$2.08	$2.09	+0.48%
Aug 21, 2024	$3.27	$2.87	-12.23%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Mdxhealth S.A. (MDXH) report earnings?

Mdxhealth S.A. (MDXH) is schdueled to report earning on Aug 14, 2025, Before Open (Confirmed).

What is Mdxhealth S.A. (MDXH) earnings time?

Mdxhealth S.A. (MDXH) earnings time is at Aug 14, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MDXH EPS forecast?

MDXH EPS forecast for the fiscal quarter 2025 (Q2) is -0.12.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing